Company intelligence / Profile preview

Newpath Partners

Boston, Massachusetts, United Statesnewpath.partners ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Newpath Partners is a Boston-based venture capital firm specializing in life sciences. The firm focuses on building biotechnology companies from the ground up by partnering with leading academic scientists to translate scientific discoveries into transformative therapies. It is known for deep involvement in early-stage company formation and has managed multiple funds, including a $350 million second fund raised in 2021. Its investments span regenerative medicine, genomics, oncology, and other high-impact areas

Therapeutic areas: Other
Modalities: Not applicable (as an investor, not a therapeutics developer)
Industry: Investors

Partnerships

Partners closely with leading academic scientists and research institutions to found new biotech ventures; specific partnerships are at the portfolio company level rather than at the fund level

Beyond the preview

Go deeper on Newpath Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Newpath Partners.

Explore the full profile